Concord Medical Services Stock Total Debt
CCM Stock | USD 0.54 0.02 3.57% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
As of the 11th of May 2024, Total Debt To Capitalization is likely to grow to 2.95. Concord | Total Debt |
Concord Medical Services Company Total Debt Analysis
Concord Medical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Concord Medical Total Debt | 3.3 B |
Most of Concord Medical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Concord Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Total Debt. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Concord Total Debt Historical Pattern
Today, most investors in Concord Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Concord Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Concord Medical total debt as a starting point in their analysis.
Concord Medical Total Debt |
Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Concord Long Term Debt
Long Term Debt |
|
Based on the latest financial disclosure, Concord Medical Services has a Total Debt of 3.3 B. This is 19.79% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 38.02% higher than that of the company.
Concord Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in total debt category among related companies.
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 806.0M | 781.1M | 556.7M | 494.1M | 341.0M | 324.0M | |
Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.6B | 3.8B |
Concord Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Concord Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Concord Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Concord Medical's value.Shares | Renaissance Technologies Corp | 2023-12-31 | 47.9 K | Rhumbline Advisers | 2023-12-31 | 5.5 K | Blackrock Inc | 2023-12-31 | 143 | Ubs Group Ag | 2023-12-31 | 101 |
Concord Fundamentals
Return On Equity | -0.28 | ||||
Return On Asset | -0.048 | ||||
Profit Margin | (0.55) % | ||||
Operating Margin | (0.98) % | ||||
Current Valuation | 7.18 B | ||||
Shares Outstanding | 43.42 M | ||||
Shares Owned By Insiders | 17.99 % | ||||
Shares Owned By Institutions | 0.10 % | ||||
Number Of Shares Shorted | 6.93 K | ||||
Price To Earning | (3.90) X | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 537.4 M | ||||
Gross Profit | (152.41 M) | ||||
EBITDA | (313.75 M) | ||||
Net Income | (531.02 M) | ||||
Cash And Equivalents | 157.39 M | ||||
Cash Per Share | 1.72 X | ||||
Total Debt | 3.3 B | ||||
Debt To Equity | 1.25 % | ||||
Current Ratio | 0.71 X | ||||
Book Value Per Share | (48.87) X | ||||
Cash Flow From Operations | (276.47 M) | ||||
Short Ratio | 0.37 X | ||||
Earnings Per Share | (0.96) X | ||||
Target Price | 1.2 | ||||
Number Of Employees | 727 | ||||
Beta | -0.33 | ||||
Market Capitalization | 24.31 M | ||||
Total Asset | 6.05 B | ||||
Retained Earnings | (4.06 B) | ||||
Working Capital | (1.33 B) | ||||
Current Asset | 1.51 B | ||||
Current Liabilities | 1.51 B | ||||
Net Asset | 6.05 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.
Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.